Post by
Hopeforthebest on Jan 05, 2024 12:18pm
Re-Imagine
Thank you proph for bring her quote up, as with all your other paid pumping dribble, if you look at her quote and adjust a few words you get the actual meaning.
Carolyn Egbert, Chair of Aeterna: “Ceapro has well-established and growing commercial operations, with potential value-creating pipeline opportunities in large and growing cosmetic and consumer health markets. We believe that the new company will have the capital resources to support this ongoing growth, in addition to continuing to maximize the value of Aeterna’s existing assets, including Macimorelin.”
Ceapro (has to) had well established as shown by the dismal performance of the company under gagnon for the last 4 qtr, with lost sales, increased costs in doing business, no new customers, no new products for the forseeable future and so.
We believe that the new company will have the capital resources to support this ongoing growth, in management payouts to the point where the new company will be bled dry in 2 -3 years and delisted in less. The pipeline that has been touted by the Ceapro management is more of a pipeline dream that really had no chance to advance forward as this would have required the expertise of a knowledgeable business man, which gagnon is not. By the way the new company will have over $5,000,000.00 in excess product rotting on the shelves, will sell at a discount to avaoid paying disposal costs.
The deal that gagnon and no show ronnie have done is the best deal for themselves and no one else. There was never a buyer out there as gagnon has ensured that the reputation of Ceapro in the business community was such that absolutely no one would even consider buying at ten cents on the dollar. This deal ensure that gagnon and his buddies will be able to increase their take from the newcompany until nothing is left. By that time they will have accumulated enough money to ensure their laish lifestyle can continue without interruption, afterall that is the quebec way, make someone else pay.